Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

I‐Wei Chang

ResearcherPublications, citations & collaboration network

I‐Wei Chang is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 104 works, 1,255 citations, an h-index of 22 and an i10-index of 42.

104
Works
1,255
Citations
22
h-index
42
i10-index

How has I‐Wei Chang's publication output changed over time?

ScholarIQpublication output · 2009–2025

Output grew0% over the shown period — from 1 works in 2009 to 1 in 2025.

1
1
3
2
1
1
1
1
20092013201520162018202120222025

What are the most-cited papers on I‐Wei Chang?

ScholarIQmost cited works
Inhibition of Viral Replication Reduces Transcriptionally Active Distinct Hepatitis B Virus Integrations With Implications on Host Gene Dysregulation
Yao‐Chun Hsu, Vithika Suri, Mindie H. Nguyen, Yen‐Tsung Huang, Chi-Yi Chen, I‐Wei Chang, Cheng‐Hao Tseng, Chun‐Ying Wu, Jaw‐Town Lin, David Z. Pan, Anuj Gaggar, Ondřej Podlaha
Gastroenterology. 202268 Citations
CDCA5 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder.
I‐Wei Chang, Victor C. Lin, Hong-Lin He, Chao‐Tien Hsu, Ching‐Chia Li, Wen‐Jeng Wu, Chun‐Nung Huang, Tingfeng Wu, Chien‐Feng Li
PubMed. 201562 CitationsOPEN ACCESS
Melanotic Xp11 Translocation Renal Cancer
I‐Wei Chang, Hsuan‐Ying Huang, Ming-Tse Sung
S37879208. 200959 Citations
Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial
Yao‐Chun Hsu, Chi-Yi Chen, I‐Wei Chang, Chi‐Yang Chang, Chun‐Ying Wu, Teng‐Yu Lee, Ming‐Shiang Wu, Ming‐Jong Bair, Jyh-Jou Chen, Chieh‐Chang Chen, Cheng‐Hao Tseng, Chi‐Ming Tai, Yen‐Tsung Huang, Wen‐Hui Ku, Lein‐Ray Mo, Jaw‐Town Lin
S23772524. 202159 Citations
The prognostic impact of lipid biosynthesis-associated markers, HSD17B2 and HMGCS2, in rectal cancer treated with neoadjuvant concurrent chemoradiotherapy
Ying-En Lee, Hong-Lin He, Yow‐Ling Shiue, Sung‐Wei Lee, Li‐Ching Lin, Tingfeng Wu, I‐Wei Chang, Hao‐Hsien Lee, Chien‐Feng Li
S12644804. 201547 Citations

Related on ScholarIQ

Taipei Medical University Hospital
Institution
Inhibition of Viral Replication Reduces Transcriptionally Active Distinct Hepatitis B Virus Integrations With Implications on Host Gene Dysregulation
Paper
CDCA5 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder.
Paper
Melanotic Xp11 Translocation Renal Cancer
Paper
Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial
Paper
The prognostic impact of lipid biosynthesis-associated markers, HSD17B2 and HMGCS2, in rectal cancer treated with neoadjuvant concurrent chemoradiotherapy
Paper
470M+ articles · free account